- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care & Insurance
Health reform tripping up Indiana wellness incentive
November 27, 2010
J.K. WallFederal health reform will trump an Indiana law that allows health insurers to offer steep discounts to employers with healthy
workers and which institute aggressive wellness programs, but experts say other provisions will motivate small firms.
MoreAHLRICHS: Turn health reform into pragmatic answers
November 27, 2010
Health reform entrepreneurship could brand Indiana as productive, healthy place for employers to operate.
MoreMCGOWAN: Reform's grandfathering option requires close look
November 27, 2010
Hugh M. McGowanWidely hailed provision of health care reform now raises host of questions.
MoreIndianapolis-area experts see bright spots amid ongoing real estate weakness
October 23, 2010
Health care shows signs of life, and multi-family buildings continue to hold their own, experts said during a recent IBJ
Power Breakfast.
MoreReform will boost health care costs, Indianapolis panel predicts
October 2, 2010
Rising costs aren't the only impact of reform, say panelists taking part in a Power Breakfast sponsored
by Indianapolis Business Journal.
State insurance chief Cutter dies
September 15, 2010
J.K. WallIndiana Insurance Commissioner Carol Cutter passed away Sept. 6 in Indianapolis after a months-long struggle with illness.
She was 67. Cutter had been on leave from the department since January.
MoreClarian moves to scoop up Morgan
September 8, 2010
J.K. WallIt looks like Clarian may be back to deal-making. The Indianapolis-based hospital system has signed a letter of intent to
absorb Morgan Hospital and Medical Center.
MoreBarron's: Brighter days ahead for WellPoint
September 8, 2010
J.K. WallIt’s been a tough year for major health insurers, but Barron’s magazine predicts a big comeback for Indianapolis-based
WellPoint Inc. and its rival UnitedHealth Group.
MoreAfter health reform, Lilly looking for more
September 1, 2010
J.K. WallThe health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives
of the
bill—and calling for further government efforts to help pharmaceutical research and development.
MorePurdue adding medical research buildings
September 1, 2010
J.K. WallUniversity will spend nearly $70 million to construct health and life science research facilities, including a drug-discovery
lab, in West Lafayette.
MoreHealth costs surge despite weak inflation
August 25, 2010
J.K. WallBen Bernanke may be worried about deflation in the economy, but there’s certainly no chance of it in health care and
insurance. Employers’ health plan premiums surged another 8 percent this year, according to results from a massive survey
by Indianapolis-based United Benefit Advisors.
MoreLilly woes take notch out of debt rating
August 25, 2010
J.K. WallEven with debt levels at Eli Lilly and Co. at paltry lows, a string of bad news finally forced Standard & Poor’s
to lower
its rating on the company’s senior unsecured debt. But the New York-based agency said it believes the Indianapolis-based
drugmaker will eventually break its string of bad luck on developing new products.
MoreExpanding hospitals target Bloomington
August 18, 2010
J.K. WallMonroe Hospital in Bloomington is the latest target in the statewide buildup by hospital systems. St. Vincent Health, St.
Francis and at least one other system have all had talks in the past month with Monroe.
MoreQ&A
August 18, 2010
J.K. WallDr. Kevin Macadaeg, vice president of the Indiana Spine Group, talked about his physician
group's decision to build a 60,000-square-foot medical office and "bioskills" lab in Carmel next year, as well
as the group's commitment to grow independently in the face of pressures from hospital acquisitions and health reform.
MoreBad news piles up for Lilly
August 18, 2010
J.K. WallWhat a tough week for Lilly. On Aug. 12, a judge struck down the Indianapolis-based drugmaker’s U.S. patent on Strattera,
which might cost the company about $450 million in annual revenue. Then, five days later, Lilly halted clinical trials on
one
of its experimental Alzheimer’s medicines, because patients did worse on the drug than on a placebo.
MoreLife sciences panel pegs bright spots in Indiana
August 14, 2010
Leaders tackle issues ranging from research to cold storage to the future of Eli Lilly and Co.
MoreRoche hit with new breed of patent suit
August 11, 2010
J.K. WallRoche Diagnostics, a Swiss company that keeps its U.S. headquarters in Indianapolis, has been sued for marking its Accu-Chek
blood glucose monitors and accessories with patents that are expired. Illinois resident David O’Neill has sued on behalf
of the U.S. government to recover damages of $500 per infraction.
MoreFor Lilly, it's a big one that got away
August 11, 2010
J.K. WallAn experimental medicine for hepatitis C that Lilly helped identify and develop is now on the cusp of market approval, with
analysts predicting as much as $2 billion in annual U.S. sales.
MoreAnalyst: Arcadia sales poised to take off
August 4, 2010
J.K. WallArcadia Resources’ DailyMed business will grow revenue 10-fold in the next three years and push the Indianapolis-based
company into profitability, according to a research report by the first analyst to officially cover the company.
MoreExchanges sprout around the country
July 28, 2010
J.K. WallWhen the Indiana Health Information Exchange launched in 2004, it was one of nine truly operational exchanges around the country.
Today, the Indianapolis-based organization is one of 73, according to the latest national survey by the eHealth Initiative.
MoreMedicare driving health care hookups
July 21, 2010
J.K. WallThe scramble by local hospitals to form their physicians and facilities into “clinically integrated” networks
that can do business with employers and health insurers has another huge motivating factor: Beginning January 2012, they can
also do business with Medicare, the massive federal program for seniors.
MoreNew rules raise stakes for Lilly drug
July 21, 2010
J.K. WallDrugmakers testing experimental Alzheimer’s medicines—including Eli Lilly and Co.—got good news last week
when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses
of the disease.
MoreHealth care reform means changes for Indiana employers
July 17, 2010
Norm Heikens, Scott Olson, J.K. WallNearly four months after President Barack Obama signed a health reform bill into law, businesses are still grappling with
its
impact on the health benefits they offer their employees.
MoreLilly, Roche dive deep into diagnostics
July 14, 2010
J.K. WallTwo Indianapolis giants—Eli Lilly and Co. and Roche Diagnostics—are working hard to pair up drugs and diagnostic
tests to gin up more sales.
MoreWellPoint strikes up chat on health reform
July 14, 2010
J.K. WallWellPoint Inc. is turning from opponent of the health care reform law passed in March to “trusted adviser.” It launched a website, healthychat.com, where company representatives answer customers’ questions about the new health reform law.
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.
It hurts me that Indianapolis is turning into Chicago south with the rampant corruption that exists in our local government. Favors and money being passed back and forth like candy.
With Kravitz's huge ego I'm sure he would be confident in his ability to lower the quality of arts coverage to the mediocre level to which the STAR aspires overall. Besides, coverage of the arts is largely nonideological and requires that opinion be based on knowledge, which would disqualify the vast majority of the dwindling staff.
I wonder which of the altruistic industry/civic leaders who are promoting this plan have tied up cheap land purchase options on the "prime waterfront real estate" surrounding this future reservoir?
I'm sorry but what are Abdul's credentials for giving legal advice and opinions? Paul Ogden and Gary Welsh would be much better candidates.